Adalimumab Biosimilar - Research Grade

Human

TNF alpha

1.0 - 5.0 mg/ml

Human IgG1 Kappa

Humanized

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human TNF alpha. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Adalimumab.

Blue ice

Tumour necrosis factor alpha (TNF-α) is a master pro-inflammatory cytokine and a heavily studied target across autoimmune and inflammatory disease research. This research-grade anti-human TNF-α recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of adalimumab, built around the TNF-α target and intended strictly for research use only. Manufactured to rigorous in vivo standards in an ultra-pure, low-endotoxin formulation, it is supplied in scalable milligram to gram quantities for heavy-usage, high-throughput laboratories. It serves as a consistent control and active reagent across preclinical work, from in vitro neutralisation screening to in vivo inflammatory disease models, ADCC studies, and biologics characterisation.

Cachectin, TNFa, Tumor necrosis factor ligand superfamily member 2, Tnfsf2

P01375

ICH3001-100ml ICH3002-100ml ICH3003-100ml

Activated monocytes, neutrophils, macrophages, T cells, B cells, NK cells, LAK cells

https://www.imgt.org/mAb-DB/